
A California state dental board should face antitrust claims over the agency’s investigation of dental products maker SmileDirectClub, a lawyer for the tele-dentistry company told the 9th Circuit on Monday, in a bid to revive a closely watched lawsuit.
Foley & Lardner partner James Dasso argued before a three-judge panel of the 9th US Circuit Court of Appeals that the federal judge in Los Angeles who dismissed the company’s complaint applied the wrong standard in assessing its claims that the board participated in an anticompetitive agreement to suppress its entry into the market.
“The district court required us to plead not only an agreement, and that the agreement restrain trade, but also that the agreement fell outside of the regulatory authority of the board,” Dasso argued.
SmileDirectClub allows patients to have their teeth scanned by technicians, who are not dentists, and have those scans sent to orthodontists who use them to make clear braces, without seeing the patients directly. The braces are then sent to patients by mail.
“An entire new disruptive model is coming into the marketplace, and that model is being met with resistance by the dental board,” Dasso told Circuit Judges M. Margaret McKeown and Jacqueline Nguyen, who heard arguments with US District Judge Royce Lamberth of Washington, DC, sitting by designation.
“The idea that you can do these things over the internet more cheaply and more conveniently really presents a major threat to the existing dentists and orthodontists,” Dasso said.
SmileDirectClub sued the dental board in 2019 in US District Court for the Central District of California, accusing it of pursuing an “aggressive, anticompetitive campaign of harassment and intimidation,” against it and alleging violations of the Sherman Act.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas